Cupertino, CA, United States of America

Shu-Hai Zhao

USPTO Granted Patents = 25 


 

Average Co-Inventor Count = 3.1

ph-index = 5

Forward Citations = 135(Granted Patents)


Location History:

  • Sunnydale, CA (US) (1999)
  • Sunnyvale, CA (US) (1999 - 2013)
  • Cupertino, CA (US) (2009 - 2016)

Company Filing History:


Years Active: 1999-2016

Loading Chart...
Loading Chart...
Loading Chart...
25 patents (USPTO):Explore Patents

Title: Innovations by Shu-Hai Zhao: Pioneering Antiviral Compounds

Introduction

Shu-Hai Zhao, based in Cupertino, California, stands out in the field of medicinal chemistry with an impressive portfolio of 25 patents. His work primarily focuses on antiviral compounds and their applications in treating critical viral infections. Zhao's groundbreaking innovations exemplify the intersection of science and technology, particularly in pharmaceuticals.

Latest Patents

Among his latest patents, the invention of antiviral compounds for the treatment of hepatitis C virus (HCV) infection is particularly noteworthy. This invention encompasses compounds, compositions, and methods that significantly contribute to the therapeutic landscape for HCV. In addition, Zhao has developed novel indazole compounds aimed at the treatment and prophylaxis of respiratory syncytial virus infection. The compounds described in this patent reveal unique structures with defined properties, paving the way for new treatment options.

Career Highlights

Zhao's career includes valuable contributions to major pharmaceutical companies, such as Roche Palo Alto LLC and Syntex (U.S.A.) Inc. His experience in these organizations has allowed him to refine his expertise in drug development and research, leading to significant advancements in antiviral therapies.

Collaborations

Throughout his career, Shu-Hai Zhao has collaborated with notable professionals in the field, including Jacob Berger and Robin D. Clark. These partnerships have fostered an environment of creativity and innovation, resulting in impactful research and development outcomes.

Conclusion

Shu-Hai Zhao's extensive experience and innovative approach to drug discovery continue to influence the field of antiviral research. With his impressive patent portfolio and collaborative efforts, he remains a key figure in the ongoing battle against viral infections, contributing to the enhancement of public health through science and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…